In this task, you're given a paragraph and title from the research paper. Your task is to classify whether the given title is suitable or not for the research paper based on the given paragraph. Return "True" if title is proper according to paragraph else "False".

Q: Paragraph: Next year will mark the 100th anniversary of the Michaelis-Menten equation [1], one of the most important and well known models in enzymology. Remarkable progress in enzymology over the past hundred years has not only provided deep insight into biological processes, but also has dramatically changed our lives. However, because of limitations in available techniques, enzymologists primarily investigate the in vitro properties and catalytic mechanisms of individual enzymes. Thus, they often fail to address a fundamental scientific question: how are biological processes, most of which are chemical reactions catalyzed by enzymes, coordinated in space and time to produce a living organism [2]? Fortunately, applications of new techniques and, in particular, wide acceptance of the idea of systems have enabled enzymologists to begin studying enzymes in the context of dynamic, complicated biological systems in recent years. Many excellent reviews and research articles on enzymology have been published in the past few years. These articles highlight the latest developments in enzymology, and should prove helpful for understanding how to best integrate the idea of systems into enzymology research. In living organisms, protein post-translational modification (PTM) pathways are large and interconnected networks. Via reversible or irreversible covalent modifications, allo-steric regulations of PTM enzymes and cross-talk of PTM pathways, PTM networks enable organisms to respond to stimuli faster than is possible through gene transcription regulation. Therefore, PTM enzymes, as key nodes of biological networks, are a recent focus of attention. 
 Title: SCIENCE CHINA A glimpse of enzymology within the idea of systems

A: False
****
Q: Paragraph: Inspired by bioactive biaryl-containing natural products found in plants and the marine 19 environment, a series of synthetic compounds belonging to the azaBINOL chiral ligand family 20 was evaluated for antiviral activity against HIV-1. Testing of 39 unique azaBINOLs in a single-21 round infectivity assay resulted in the identification of three promising antiviral compounds, 22 including 7-isopropoxy-8-(naphth-1-yl)quinoline (azaBINOL B#24), which exhibited low-23 micromolar activity. The active compounds and several close structural analogues were further 24 tested against three different HIV-1 envelope pseudotyped viruses as well as in a full-virus 25 replication system (EASY-HIT). Mode-of-action studies using a time-of-addition assay indicated 26 that azaBINOL B#24 acts after viral entry but before viral assembly and budding. HIV-1 reverse 27 transcriptase (RT) assays that individually test for polymerase and RNase H activity were used to 28 demonstrate that B#24 inhibits RNase H activity, most likely allosterically. Further binding 29 analysis using bio-layer interferometry (BLI) showed that B#24 interacts with HIV-1 RT in a 30 highly specific manner. These results indicate that azaBINOL B#24 is a potentially viable, novel 31 
 Title: Biological Evaluation of Molecules of the azaBINOL Class as Antiviral Agents: 1 Specific Inhibition of HIV-1 RNase H Activity by 7-Isopropoxy-8-(naphth-1-yl)quinoline 2 3 4 5

A: False
****
Q: Paragraph: Causative pathogens of pneumonia in children can be diffi cult to identify. Streptococcus pneumoniae is the most common bacterial cause of pneumonia in children. Tachypnea is the most reliable clinical predictor of pneumonia in children. Laboratory and radiologic testing offers limited diagnostic benefi t. Probably the greatest challenge in the approach to children with pneumonia is that the microbiologic etiology is diffi cult to identify. This is primarily due to limitations of diagnostic testing modalities: blood cultures, antigen testing and antibody titers, and the need for invasive means to retrieve specimens. 1,4 Two studies illustrate our limited ability to diagnose the etiology of pneumonia in children. In a prospective study of 168 ambulatory children with CAP, an etiologic agent was identifi ed in only 43% of cases. 5 These included Streptococcus pneumoniae (27%), Mycoplasma pneumoniae (7%) and Chlamydia pneumoniae (6%). Patients with S. pneumoniae frequently had a mixed infection (40%). Of 157 patients tested for viral infection, 20% were positive by culture and/or direct fl uorescent antibody test. Viral etiologies identifi ed included respiratory syncytial virus (RSV), infl uenza viruses A and B, parainfl uenza viruses 1 and 3, adenovirus, enterovirus, cytomegalovirus, and herpes simplex virus. All viral isolates were identifi ed in children less than 8 years of age. 5 A similar study, in 254 hospitalized children with CAP, identifi ed a potential causative agent in 85% of cases. 6 Extensive diagnostic testing accounted for the relatively high yield in this study. Similar etiologies identifi ed, in decreasing frequency of occurrence, included S. pneumoniae, Haemophilus infl uenzae, M. pneumoniae, Moraxella catarrhalis, C. pneumoniae, Streptococcus pyogenes, and Chlamydia trachomatis. Viral etiologies included (most common to least common) RSV, rhinovirus, parainfl uenza viruses 1 through 3, adenovirus, infl uenza virus A and B, coronavirus, human herpesvirus 6, Epstein-Barr virus, and varicella-zoster virus. Mixed viralbacterial infections were detected in 30% of patients, and 41% of patients had more than one microbiologic agent identifi ed. Of interest, of 93 patients with S. pneumoniae, only one had a positive blood culture. The remaining 92 patients were diagnosed based solely on serologic evidence. 6 A prospective analysis seeking to identify etiologic agents via a pneumolysin-based polymerase chain reaction assay identifi ed a respiratory pathogen in 79% of 154 pediatric patients with lower respiratory tract infection. The most common etiologic agent was S. pneumoniae (44%). Of 68 patients with S. pneumoniae infection, 18% had a coinfection with another bacteria and 31% had a co-infection with a virus. Atypical agents (M. pneumoniae and C. pneumoniae) accounted for 22% of all infections (14% and 9%, respectively). The most common viral etiologies included 
 Title: Pneumonia Key Points

A:
False
****